Preliminary evidence of anxiolytic effects of the CRF 1 receptor antagonist R317573 in the 7.5% CO 2 proof-of-concept experimental model of human anxiety
We have validated the use of prolonged inhalation of 7.5% carbon dioxide (CO 2 ) as a human model of anxiety and have shown that drugs from two prototypical classes of anxiolytics, benzodiazepines and a serotonin reuptake inhibitor, attenuate CO 2 -induced symptoms ( Bailey et al., 2007a ). Preclini...
Gespeichert in:
Veröffentlicht in: | Journal of psychopharmacology (Oxford) 2011-09, Vol.25 (9), p.1199-1206 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!